Steve Brozak

Stock Analyst at WBB Securities

(0)
# 5422
Out of 5,441 analysts
14
Total ratings
Success rate
Average return
7 Stocks
Name Action PT Current % Upside Ratings Updated
CDTX Cidara Therapeutics
Reiterates: Strong Buy
45 45
61.9 -27.3% 2 Jun 23, 2025
MRKR Marker Therapeutics
Reiterates: Strong Buy
13 13
1.19 950.42% 1 Apr 1, 2025
CFRX ContraFect
Upgrades: Strong Buy
560
n/a n/a 3 Jun 8, 2022
PRTK Paratek Pharmaceutic...
Upgrades: Strong Buy
11
2.23 393.27% 2 Feb 10, 2022
CWBR CohBar
Upgrades: Buy
150
n/a n/a 2 Aug 11, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
75 100
4.13 2321.31% 1 Jun 18, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Buy
17000 16000
n/a n/a 3 May 28, 2021